Youll have ongoing access to medical support and follow-up care to help you stay on track and maximize results safely
Food and Drug Administration approval, the 25 mg oral semaglutide tablet (brand name: Wegovy), a once-daily pill became available in the United States in early January 2026 for chronic weight management and for reducing the risk of major adverse cardiovascular events in adults living with obesity or overweight and established cardiovascular disease
It is unknown if tirzepatide increases the risk of tumors in humans, as the incidence of these events is too low to establish causality
Pre-filled vs lyophilised: what changes operationally Because the pen is pre-filled in solution, there is no reconstitution step
What I Tell My Patients, Family and Friends About Menopause and Hunger
However, several challenges hinder its large-scale application and industrial adoption